Simultaneous in vivo RP-HPLC-DAD quantification of multiple-component and drug-drug interaction by pharmacokinetics, using 6,7-dimethylesculetin, geniposide and rhein as examples

Biomedical Chromatography

Volumn 26, Issue 7, 2012, Pages 844-850

  Zhang, Aihua ^a   Sun, Hui ^a   Wang, Xijun ^a   Jiao, Guozheng ^a   Yuan, Ye ^a   Sun, Wenjun ^a  

^a HEILONGJIANG UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Drug drug interaction; Multiple component; Pharmacokinetics; Synergism; Synergistic effect; Traditional Chinese medicine

Indexed keywords

DRUG INTERACTIONS; MEDICINE;

DRUG-DRUG INTERACTIONS; GENIPOSIDE; HPLC/DAD; IN-VIVO; MULTIPLE COMPONENTS; RP-HPLC; SYNERGISM; SYNERGISTIC EFFECT; THERAPEUTIC EFFICACY; TRADITIONAL CHINESE MEDICINE;

PHARMACOKINETICS;

CARBON; CARBON 18; GENIPOSIDE; METHANOL; RHEIN; SCOPARONE; UNCLASSIFIED DRUG;

ACCURACY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTENNA; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CHEMICAL COMPOSITION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DETERMINATION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG POTENTIATION; FILTRATION; IN VIVO STUDY; INJECTION; LIMIT OF QUANTITATION; MALE; MAXIMUM PLASMA CONCENTRATION; MEAN RESIDENCE TIME; NONHUMAN; PHARMACOLOGICAL PARAMETERS; PRECIPITATION; RAT; RELIABILITY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY DIODE ARRAY DETECTOR; SENSITIVITY AND SPECIFICITY; SPECTRAL SENSITIVITY; TIME TO MAXIMUM PLASMA CONCENTRATION;

RATTUS;

EID: 84862163326     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.1739     Document Type: Article

References (24)

1. Chait R, Craney A and Kishony R. Antibiotic interactions that select against resistance. Nature 2007; 446: 668-671.
2. Drews J. Drug discovery: a historical perspective. Science 2000; 287: 1960-1964.
3. Frew AJ, Lindemann RK, Martin BP, Clarke CJ, Sharkey J, Anthony DA, Banks KM, Haynes NM, Gangatirkar P, Stanley K, Bolden JE, Takeda K, Yagita H, Secrist JP, Smyth MJ and Johnstone RW. Combination therapy of established cancer using a histone deacetylase inhibitor and a TRAIL receptor agonist. Proceedings of the National Academy of Sciences, USA 2008; 105: 11317-11322.
4. Ghosh M, Manna P and Sil PC. Protective role of a coumarin-derived schiff base scaffold against tertiary butyl hydroperoxide (TBHP)-induced oxidative impairment and cell death via MAPKs, NF-κB and mitochondria-dependent pathways. Free Radical Research 2011; 45: 620-637.
5. Layek B, Kumar TS, Trivedi RK, Mullangi R and Srinivas NR. Development and validation of a sensitive LC-MS/MS method with electrospray ionization for quantitation of rhein in human plasma: application to a pharmacokinetic study. Biomedical Chromatography 2008; 22: 616-624.
6. Lv H, Sun H, Sun W, Liu L, Wang P, Wang X and Cao H. Pharmacokinetic studies of a Chinese triple herbal drug formula. Phytomedicine 2008; 15: 993-1001.
7. Richman DD, Margolis DM, Delaney M, Greene WC, Hazuda D and Pomerantz RJ. The challenge of finding a cure for HIV infection. Science 2009; 323: 1304-1307.
8. Tang WF, Huang X, Yu Q, Qin F, Wan MH, Wang YG and Liang MZ. Determination and pharmacokinetic comparison of rhein in rats after oral dosed with Da-Cheng-Qi decoction and Xiao-Cheng-Qi decoction. Biomedical Chromatography 2007; 21: 1186-1190.
9. Tong L, Wan M, Zhou D, Gao J, Zhu Y and Bi K. LC-MS/MS determination and pharmacokinetic study of albiflorin and paeoniflorin in rat plasma after oral administration of Radix Paeoniae Alba extract and Tang-Min-Ling-Wan. Biomedical Chromatography 2010; 24: 1324-1331.
10. Wang ZY and Chen Z. Acute promyelocytic leukemia: from highly fatal to highly curable. Blood 2008a; 111: 2505-2515.
11. Wang L, Zhou GB, Liu P, Song JH, Liang Y, Yan XJ, Xu F, Wang BS, Mao JH, Shen ZX, Chen SJ and Chen Z. Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia. Proceedings of the National Academy of Sciences, USA 2008a; 105: 4826-4831.
12. Wang X, Lv H, Sun H, Liu L, Yang B, Sun W, Wang P, Zhou D, Zhao L, Dou S, Zhang G and Cao H. Metabolic urinary profiling of alcohol hepatotoxicity and intervention effects of Yin Chen Hao Tang in rats using ultra-performance liquid chromatography/electrospray ionization quadruple time-of-flight mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis 2008b; 48: 1161-1168.
13. Wang X, Sun W, Sun H, Lv H, Wu Z, Wang P, Liu L and Cao H. Analysis of the constituents in the rat plasma after oral administration of Yin Chen Hao Tang by UPLC/Q-TOF-MS/MS. Journal of Pharmaceutical and Biomedical Analysis 2008c; 46: 477-490.
14. Wang X, Lv H, Sun H, Jiang X, Wu Z, Sun W, Wang P, Liu L and Bi K. Quality evaluation of Yin Chen Hao Tang extract based on fingerprint chromatogram and simultaneous determination of five bioactive constituents. Journal of Separation Science 2008d; 31: 9-15.
15. Wang X, Lv H, Sun H, Sun W, Liu L, Wang P and Cao H. Simultaneous determination of 6, 7-dimethylesculetin and geniposide in rat plasma and its application to pharmacokinetic studies of Yin Chen Hao Tang preparation. Arzneimittelforschung 2008e; 58: 336-341.
16. Wang XN, Xu LN, Peng JY, Liu KX, Zhang LH and Zhang YK. In vivo inhibition of S180 tumors by the synergistic effect of the Chinese medicinal herbs Coptis chinensis and Evodia rutaecarpa. Planta Medica 2009; 75: 1215-1220.
17. Wu SY, Wang GF, Liu ZQ, Rao JJ, Lü L, Xu W, Wu SG and Zhang JJ. Effect of geniposide, a hypoglycemic glucoside, on hepatic regulating enzymes in diabetic mice induced by a high-fat diet and streptozotocin. Acta Pharmacologica Sinica 2009; 30: 202-208.
18. Zan B, Shi R, Wang T, Wu J, Ma Y and Cheng N. Simultaneous quantification of multiple active components from Xiexin decoction in rat plasma by LC-ESI-MS/MS: application in pharmacokinetics. Biomedical Chromatography 2011; 25: 816-826.
19. Zhang ZJ. Shanghanlun. People's Hygiene: Beijing, 2005; 8.
20. Zhang QY, Mao JH, Liu P, Huang QH, Lu J, Xie YY, Weng L, Zhang Y, Chen Q, Chen SJ and Chen Z. A systems biology understanding of the synergistic effects of arsenic sulfide and Imatinib in BCR/ABL-associated leukemia. Proceedings of the National Academy of Sciences, USA 2009; 106: 3378-3383.
21. Zhang A, Sun H, Wang Z, Sun W, Wang P and Wang X. Metabolomics: towards understanding traditional Chinese medicine. Planta Medica 2010a; 76: 2026-2035.
22. Zhang XW, Yan XJ, Zhou ZR, Yang FF, Wu ZY, Sun HB, Liang WX, Song AX, Lallemand-Breitenbach V, Jeanne M, Zhang QY, Yang HY, Huang QH, Zhou GB, Tong JH, Zhang Y, Wu JH, Hu HY, de Thé H, Chen SJ and Chen Z. Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML. Science 2010b; 328: 240-243.
23. Zhang L, Ren X, Alt E, Bai X, Huang S, Xu Z, Lynch PM, Moyer MP, Wen XF and Wu X. Chemoprevention of colorectal cancer by targeting APC-deficient cells for apoptosis. Nature 2010c; 464: 1058-1061.
24. Zhao YL, Wang JB, Zhou GD, Shan LM and Xiao XH. Investigations of free anthraquinones from rhubarb against alpha-naphthylisothiocyanate-induced cholestatic liver injury in rats. Basic Clinical Pharmacology and Toxicology 2009; 104: 463-469.